Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)

Japan Esophageal Oncology Group/Japan Clinical Oncology Group

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)'. Together they form a unique fingerprint.

Medicine & Life Sciences